Selexipag contraindicated with strong CYP2C8 inhibitorsReactions Weekly -doi:10.1007/s40278-017-32203-2NoneSpringer International PublishingReactions Weekly
Selexipag contraindicated with strong CYP2C8 inhibitorsReactions Weekly -doi:10.1007/s40278-017-32203-2NoneSpringer International PublishingReactions Weekly